A long-acting injectable called lenacapavir, taken only twice a year, is on the brink of transforming HIV prevention.

HIV recency test is a rapid test identifies whether HIV-1 infection in a person is recent (usually within a year or less)or long-term.

Following the results of the 2018 demographic and health survey, which revealed an estimated HIV prevalence of 2.7%, Cameroon has adopted th